Immunization Programs
Mostrando 25-36 de 41 artigos, teses e dissertações.
-
25. Evaluating the benefits of increasing measles immunization rates.
OBJECTIVE: To calculate the cost-effectiveness, expressed in dollars per quality-adjusted life years (QALY), of increasing measles immunization rates. DATA SOURCES/STUDY DESIGN: Published data were supplemented by expert opinion. We determined the cost savings and value of the health benefits from averting a single case of measles. Next we examined the U. S.
-
26. One country, 13 immunization programs
-
27. Public health and the law. Immunization programs: further legal developments.
-
28. Public Health and the Law. Mass Immunization Programs: A Special Legal Area?
-
29. Evaluation of a health promotion demonstration program for the rural elderly.
OBJECTIVE. This article evaluates a demonstration program that extended coverage for disease prevention/health promotion services to Medicare beneficiaries. STUDY SETTING/DATA SOURCES. Community-dwelling Medicare beneficiaries who lived in five rural counties in northwest Pennsylvania were recruited between May and December 1989. The demonstration lasted 18
-
30. Update on Diagnosis, Management, and Prevention of Hepatitis B Virus Infection
Acute and chronic hepatitis B virus (HBV) infection is a leading cause of liver disease worldwide. It is estimated that approximately 350 million people worldwide have chronic HBV infection and that 1 million persons die each year from HBV-related chronic liver disease. In the past decade, significant progress in the understanding of the molecular virology a
American Society for Microbiology.
-
31. The past, present, and future of pertussis. The role of adults in epidemiology and future control.
Pertussis is a severe epidemic disease that causes significant morbidity and mortality in unimmunized children. It is now clear, however, that adults with atypical disease account for many of the cases and are often responsible for transmission to susceptible infants. Because of the extent of unrecognized pertussis in the adult population, mass pediatric imm
-
32. Effect of parenteral immunization on the local immunoglobulin A response of the intestine to Shigella flexneri antigens.
Most traditional methods of immunization involve parenteral vaccines. Using a chronically isolated ileal loop model as the probe, we examined the effect of a primary parenteral immunization on the local immune response of the intestine. Secretions from isolated ileal loops of rabbits given a primary parenteral immunization with Shigella flexneri without adju
-
33. Aging and the Immune Response to Tetanus Toxoid: Diminished Frequency and Level of Cellular Immune Reactivity to Antigenic Stimulation
The period of efficacious immune reactivity afforded by tetanus immunization and the need for continuing some forms of tetanus vaccination programs have been the subjects of recent debates. Our studies demonstrate that the level of antitetanus immunity based on immunological memory (i.e., cellular immune responsiveness) varies dramatically as a function of a
American Society for Microbiology.
-
34. Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen.
We studied the interactions of hepatitis B vaccine with other vaccines used in the World Health Organization expanded programs of immunization. Three groups of Senegalese children were vaccinated with hepatitis B vaccine (HB) alone, diphtheria-tetanus-pertussis (DTP)-polio vaccine alone, or a combination of hepatitis B vaccine and DTP-polio vaccines simultan
-
35. Maternal and Fetal Well-being
Pregnancy outcomes can be improved by following modern recommendations for personal health maintenance. Adequate caloric intake, reflected by a weight gain of about 10 to 12.3 kg (22 to 27 lb) for women of average build, is associated with the lowest rate of perinatal mortality. Maternal dietary protein supplementation should generally be avoided because it
-
36. A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs
A vaccine that would engage the mucosal immune system against a broad range of HIV-1 subtypes and prevent epithelial transmission is highly desirable. Here we report fusing the mucosal targeting B subunit of cholera toxin to the conserved galactosylceramide-binding domain (including the ELDKWA-neutralizing epitope) of the HIV-1 gp41 envelope protein, which m
National Academy of Sciences.